HomeELVN • NASDAQ
add
Enliven Therapeutics Inc
Nakaraang pagsara
$27.77
Sakop ng araw
$27.38 - $28.91
Sakop ng taon
$13.30 - $30.98
Market cap
1.67B USD
Average na Volume
783.98K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 34.28M | 27.47% |
Net na kita | -29.67M | -27.99% |
Net profit margin | — | — |
Kita sa bawat share | -0.48 | — |
EBITDA | -34.24M | -27.68% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 462.62M | 47.59% |
Kabuuang asset | 476.17M | 46.17% |
Kabuuang sagutin | 16.57M | 4.10% |
Kabuuang equity | 459.60M | — |
Natitirang share | 59.80M | — |
Presyo para makapag-book | 3.59 | — |
Return on assets | -17.73% | — |
Return on capital | -18.30% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -29.67M | -27.99% |
Cash mula sa mga operasyon | -15.84M | 7.93% |
Cash mula sa pag-invest | 12.38M | 1,602.75% |
Cash mula sa financing | 623.00K | -98.44% |
Net change in cash | -2.84M | -112.07% |
Malayang cash flow | -14.30M | -19.78% |
Tungkol
Itinatag
2016
Headquarters
Website
Mga Empleyado
60
